Increasing access to HIV prevention for young sexual and gender minority men in rural North Carolina
Meet me where I am: A multilevel strategy to increase PrEP uptake and persistence among young sexual and gender minority men in rural NC
This study is working to help young men from different sexual and gender backgrounds in rural North Carolina get and stay on PrEP, a medication that helps prevent HIV, by tackling the challenges they face and providing support and education in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10819510 on NIH RePORTER |
What this research studies
This research aims to improve the uptake and persistence of pre-exposure prophylaxis (PrEP) among young sexual and gender minority men in rural North Carolina. It addresses the significant barriers these populations face in accessing PrEP, which is crucial for preventing HIV infections. The study employs a multilevel strategy that includes community engagement, education, and support services to enhance awareness and accessibility of PrEP. By focusing on the unique challenges faced by these communities, the research seeks to create tailored interventions that can effectively increase PrEP usage.
Who could benefit from this research
Good fit: Ideal candidates for this research are young sexual and gender minority men living in rural North Carolina who are at risk for HIV.
Not a fit: Patients who do not identify as sexual or gender minorities or those who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of new HIV infections among young sexual and gender minority men in rural areas.
How similar studies have performed: Previous research has shown that targeted interventions can successfully increase PrEP uptake in underserved populations, indicating a promising approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Rutstein, Sarah E. — Univ of North Carolina Chapel Hill
- Study coordinator: Rutstein, Sarah E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.